From insomnia studies to the effects of early cannabis use on mental health, here are some recently published studies that should be on your radar.
Historically, cannabis has been an area of inadequate research in most cases, thanks to its status as an illegal substance.
but, Legalization Becoming more common around the world, scientists are finally given the freedom to study the effects of plants and their potential uses for treating a wide range of conditions.
Here are five important cannabis studies over the last two months.
Cannabis consumers report a “significant improvement” in the symptoms of insomnia
Cannabis is a popular option for self-healing insomnia There is case evidence that CBD and THC may improve sleep. There is still a lack of research to support these claims, Retrospective cohort study Announced in April of this year, we have confirmed that cannabis-derived products can help people suffering from this condition.
In a Canadian study depressionAnxiety about using cannabis for insomnia, or both, has noticed a “significant” improvement after taking the drug.
Studies published in the journal BMC Psychiatry, We analyzed data from a cohort of 677 people with a total of 8,476 sessions recorded. As a result, cannabis was recognized to be effective in managing anxiety / depression-related insomnia in all groups, regardless of age or gender.
The study also looked at which types of cannabis were more effective and found that indica-dominated, indica-hybrid and sativa-dominated strains were more effective in depression than CBD-dominated strains.for anxiety In comorbidity conditions, the research team found few differences between the strains.
“Current studies highlight the need for a placebo-controlled trial to improve symptoms and the safety of cannabinoids for sleep in people with mood and anxiety disorders,” the researchers conclude. rice field.
First studies of that sort find that cannabis may help tackle fatigue.
A study The study, led by scientists at the University of New Mexico, found that more than 90% of subjects were inexperienced. Malaise After consuming cannabis.Studies published in the journal Medical cannabis and cannabinoids were the first to investigate the effects of over-the-counter cannabis flowers on fatigue.
In three years, about 1,200 people recorded less than 4,000 sessions of self-management of cannabis flowers. As a result, 91.94% of the subjects reported improvement in fatigue, and it was found that the average intensity decreased by 3.48 points on the scale of 0 to 10.
A few users have reported negative side effects that affect fatigue, such as lack of motivation and “couch lock”, but more users have experienced positive effects that help raise energy levels.
The researchers concluded in a summary of the paper that “the magnitude of the effects experienced and the extent of side effects are likely to depend on the individual’s metabolic status and the synergistic chemotypic properties of the plant.”
Cannabis use is associated with an increased risk of heart disease, but soy may help
A study In mice led by researchers at Stanford University, THC (a psychoactive compound found in cannabis) has been shown to cause inflammation of the cells that line blood vessels and thickening of the arteries (atherosclerosis).
Researchers have discovered that THC “has a significant adverse effect on the cardiovascular system,” but the study also “caused inflammation and atherosclerosis with small molecules naturally found in soybeans and soybeans.” Showed that you can “block”.
“As more states legalize the use of marijuana for recreational purposes, users should be aware that marijuana can cause cardiovascular side effects,” said a professor of cardiovascular medicine and radiology. can be, Stanford Cardiovascular Institute..
“But genistein is very effective in reducing marijuana-induced damage to the endothelial blood vessels without interfering with the effects of marijuana on the central nervous system, and medical marijuana users can get rid of it from a cardiovascular perspective. It could be a way to protect it. “
Two-thirds of Canadian MS patients use cannabis
A Canadian study of 344 people suffering from multiple sclerosis reported that 64.5% used medical cannabis at least once, and more than half still use medical cannabis to treat their condition. I am reporting. Cannabis was mainly used for sleep disorders, pain and spasticity.
While there is growing interest in the use of cannabis for multiple sclerosis, studies supporting anecdotal evidence have been delayed. The authors of the study said more research is needed to determine the potential treatment of MS as an official treatment.
The authors state in the conclusion of the study: “Users have reported that cannabis is moderate to very effective in treating some symptoms, and side effects are generally not serious and are not the main factor driving the discontinuation of medical cannabis. The results support the need for further research to investigate the use of medical cannabis in MS and the need to make evidence-based resources publicly available to those seeking it as a potential treatment. increase.”
Studies have found a link between cannabis frequency and delusional experiences
A study It combined the frequent use of cannabis announced last week (May 3rd) with a delusional experience. This is paranoia (which occurs when someone believes that someone is trying to harm you) or people believe that others can hear or know their thoughts. Includes thought broadcast.
Same study – published in Scientific Reports – We have found that the age at which cannabis is used has a negative relationship with visual hallucinations and hypersensitivity. This means that these experiences are more likely to be used before.
Early onset of cannabis use, rather than lifetime frequency, was associated with early risk factors.
The author states: “It provides a valuable starting point for further investigation of the complex relationship between cannabis usage patterns and specific symptoms.”
New research confirms the safety and non-toxicity of CBD
Source link New research confirms the safety and non-toxicity of CBD